AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $29,971,000 | -12.2% | 1,872,070 | -2.0% | 0.04% | -18.2% |
| Q1 2021 | $34,133,000 | +31.8% | 1,910,100 | -0.3% | 0.04% | +29.4% |
| Q4 2020 | $25,888,000 | +14.1% | 1,916,243 | -0.6% | 0.03% | +3.0% |
| Q3 2020 | $22,683,000 | +30.0% | 1,927,191 | +63.1% | 0.03% | +17.9% |
| Q2 2020 | $17,443,000 | -23.7% | 1,181,778 | +218.4% | 0.03% | -37.8% |
| Q3 2018 | $22,848,000 | +11.5% | 371,215 | +22.4% | 0.04% | +9.8% |
| Q2 2018 | $20,491,000 | +41.1% | 303,344 | +13.3% | 0.04% | +32.3% |
| Q1 2018 | $14,521,000 | -12.2% | 267,672 | -3.3% | 0.03% | -8.8% |
| Q4 2017 | $16,535,000 | +22.3% | 276,730 | -0.5% | 0.03% | +17.2% |
| Q3 2017 | $13,521,000 | – | 278,209 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |